Podcast Episodes
Back to Search
Expert Answers to Questions on PARP Inhibition for Prostate Cancer
Episode 51
In this episode, Charles J. Ryan, MD, and Neal D. Shore, MD, FACS, answer questions from a healthcare professional audience on topics related to pros…
5 years, 2 months ago
Expert Insights on Highlights From ASH 2020 on Lymphomas/CLL
Episode 50
In this episode, Jeremy S. Abramson, MD, MMSc, discusses highlights of the key data from ASH 2020 on the treatment of patients with lymphomas/CLL, wi…
5 years, 3 months ago
Improving Outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer: Global Insights on Evolving Practice Standards
Episode 49
In this episode, Enriqueta Felip, MD, PhD, and Matthew Gubens, MD, MS, discuss evolving practice standards for EGFR-mutated non-small-cell lung cance…
5 years, 3 months ago
Targeting FGFR in Urothelial Cancer and Beyond
Episode 48
In this episode, Ignacio Durán, MD, PhD, and Alison Birtle, MD, FRCP, FRCR, interpret the latest clinical data on targeting FGFR in urothelial cancer…
5 years, 3 months ago
Expert Answers to HCP Questions on Pancreatic Cancer Treatment
Episode 47
In this episode, Michael J. Pishvaian, MD, PhD, and Rachna Shroff, MD, answer audience questions from a live CCO webinar focused on current best prac…
5 years, 3 months ago
Expert Answers to HCP Questions on CAR T-Cell Therapies in Lymphoma
Episode 46
In this episode, Frederick L. Locke, MD, answers audience questions from a live CCO Webinar focused on emerging strategies in the use of CAR T-cell t…
5 years, 3 months ago
Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer
Episode 45
In this episode, D. Ross Camidge, MD, PhD, and Joel W. Neal, MD, PhD, answer questions on investigational antibody-drug conjugates for advanced NSCLC…
5 years, 3 months ago
Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities
Episode 44
In this episode, Noopur Raje, MD, answers audience questions from a live CCO Webinar focused on emerging strategies in the use of CAR T-cell therapy …
5 years, 3 months ago
Expert Insights on Highlights From ASH 2020 on Multiple Myeloma
Episode 43
In this episode, Dr. Shaji Kumar from the Mayo Clinic and Dr. Sagar Lonial from Emory University discuss highlights of the key data from ASH 2020 on …
5 years, 3 months ago
Expert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias
Episode 42
In this episode, Jorge Cortes, MD, and Eunice S. Wang, MD, discuss the clinical implications of 3 key studies in acute myeloid leukemia (AML) and chr…
5 years, 4 months ago